Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force

By Danélia Botes

April 19, 2023

Benefit-risk assessment is a crucial step in evaluating the safety and efficacy of medical products. Quantitative benefit-risk assessment (qBRA) is a set of techniques that can help drug and medical device developers and regulators to evaluate the benefit-risk balance of medical products.

This report outlines five main steps for developing qBRAs. The first step is to identify the research question and specify the role of external experts. The second step involves developing a formal analysis model by selecting benefit and safety endpoints, eliminating double counting, and considering attribute value dependence. The third step is to choose a preference elicitation method, frame attributes appropriately, and evaluate the quality of the data. The fourth step involves normalizing preference weights, conducting base-case and sensitivity analyses, and analyzing the effect of preference heterogeneity. Finally, the fifth step is to communicate the results efficiently to decision makers and other stakeholders.

In addition to these steps, ISPOR provides a checklist for reporting qBRAs. By following these emerging good practices, drug and medical device developers and regulators can better evaluate and communicate the benefit-risk balance of medical products.

Reference url

Recent Posts

early aortic stenosis surgery
        

Earlier Surgery Recommended for Heart-Valve Patients: New Study Insights

💔 Are we waiting too long for heart health interventions?

A recent study suggests that patients with severe aortic stenosis may benefit significantly from earlier surgical intervention, overturning traditional ‘wait and see’ practices. This shift, utilizing minimally invasive techniques, could prove vital in reducing unexpected hospitalizations and improving overall outcomes for patients, especially seniors. Learn more about this pivotal research that may redefine treatment protocols in cardiology!

#SyenzaNews #HealthcareInnovation #ClinicalTrials #MedTech #HealthTech

cross-border health surveillance
   

Strengthening Cross-Border Health Surveillance in Africa

🌍 How can enhanced cross-border surveillance improve public health security in Africa?

Check out the Africa CDC’s newly launched Strategic Framework that aims to bolster collaboration and information sharing among African Union Member States. This initiative tackles the challenges of health threats linked to population movement by promoting robust systems for surveillance and response. Discover how these efforts can pave the way for safer communities across the continent!

#SyenzaNews #globalhealth #HealthcareInnovation #DigitalTransformation #HealthTech

regional immunization framework
              

Strengthening Immunisation in the Eastern Mediterranean: WHO Launches Regional Framework

🌍 How can strengthening immunisation in the Eastern Mediterranean transform public health?

The recent launch of the regional framework by WHO is a crucial step towards enhancing vaccine access and addressing disparities in coverage. This initiative, inaugurated in Doha, aims to save millions of lives by ensuring everyone has access to essential vaccines, especially in conflict-affected areas. Discover how this framework can pave the way for healthier communities!

#SyenzaNews #GlobalHealth #HealthForAll #HealthcareInnovation #Immunisation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.